Platinated benzonaphthyridone is a stronger inhibitor of poly(ADP-ribose) polymerase-1 and a more potent anticancer agent than is the parent inhibitor

European Journal of Medicinal Chemistry
Beilei WangGuangyu Zhu

Abstract

Inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1) have shown to be promising in clinical trials against cancer and other diseases, and lots of efforts have been put into the development of organic compounds as more potent PARP-1 inhibitors. Here we describe a strategy to conveniently obtain metal-based PARP-1 inhibitors with enhanced biological activities by conjugating platinum moiety with an original inhibitor, e.g., benzonaphthyridone. Based on the structure-activity relationship analysis of PARP-1 inhibitors, three platinated PARP-1 inhibitors were designed, and the complexes were synthesized and characterized. Complex 3 presented significantly enhanced cytotoxicity against a panel of human cancer cells and a 10-fold increased inhibitory effect against recombinant PARP-1 compared with the original PARP-1 inhibitor. Complex 3 was as cytotoxic as cisplatin and its spectrum of anticancer activity was identical to that of cisplatin. The complex was able to enter into cancer cells efficiently, bind to DNA well, and block cell cycle at G₂/M phase, indicating that complex 3 is an effective anticancer agent with a distinct mechanism of action. Our study implies that the conjugation of platinum with PARP-1 inhibitors could be a v...Continue Reading

References

Sep 1, 1994·Molecular and Cellular Biochemistry·M Banasik, K Ueda
Dec 26, 2001·Chemical Reviews·E R Jamieson, S J Lippard
Sep 12, 2002·Pharmacological Reviews·László Virág, Csaba Szabó
Apr 2, 1963·Biochemical and Biophysical Research Communications·P CHAMBONP MANDEL
Jul 27, 2004·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Jean-Christophe AméGilbert de Murcia
Mar 25, 2005·Nature Reviews. Drug Discovery·Dong Wang, Stephen J Lippard
Apr 20, 2005·Expert Reviews in Molecular Medicine·Nicola J Curtin
May 3, 2005·Nature Reviews. Drug Discovery·Prakash Jagtap, Csaba Szabó
Jan 19, 2007·Journal of Medicinal Chemistry·Helena GradisarRoman Jerala
Apr 26, 2007·Chemical Reviews·Yongwon Jung, Stephen J Lippard
Mar 13, 2008·Dalton Transactions : an International Journal of Inorganic Chemistry·Xiaoyong Wang, Zijian Guo
Nov 18, 2008·Journal of Medicinal Chemistry·Zhidong MaUlrich Bierbach
Oct 6, 2009·Bioorganic & Medicinal Chemistry·Hee-Kyung RheeHea-Young Park Choo
Dec 22, 2009·Dalton Transactions : an International Journal of Inorganic Chemistry·Katherine S Lovejoy, Stephen J Lippard
Jun 17, 2010·Biochemistry·Guangyu ZhuStephen J Lippard
Oct 30, 2010·Dalton Transactions : an International Journal of Inorganic Chemistry·Martin HuxleyMichael J Hannon
Oct 30, 2010·Dalton Transactions : an International Journal of Inorganic Chemistry·Carlos Sanchez-CanoMichael J Hannon
Mar 5, 2011·Journal of Medicinal Chemistry·Filipa MendesAngela Casini
Jun 18, 2011·Dalton Transactions : an International Journal of Inorganic Chemistry·Shengde WuZijian Guo
Mar 1, 2012·European Journal of Medicinal Chemistry·Shridhar S KulkarniTanaji T Talele
Jun 21, 2012·Nature Reviews. Molecular Cell Biology·Bryan A Gibson, W Lee Kraus
Jul 10, 2012·Proceedings of the National Academy of Sciences of the United States of America·Ga Young ParkStephen J Lippard
Jun 7, 2013·Inorganic Chemistry·Timothy C JohnstoneStephen J Lippard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.